Source - LSE Regulatory
RNS Number : 8343D
Feedback PLC
21 February 2024
 

 

Feedback plc

 

Feedback opens opportunity in UK private healthcare

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, announces that radiology specialist Medical Imaging Partnership ("MIP") has agreed to pilot Bleepa-CareLocker, in order to deliver multiple clinical pathways to its customers in the UK private healthcare sector.

 

The agreement to pilot, enables both parties to evaluate how a pathway that enables a 'straight to diagnostic' stage followed by an 'asynchronous MDT' review, can translate from the NHS model and deliver impact within private healthcare journeys. The pilot will formally commence on a paid basis after an initial evaluation and planning period. It is anticipated that Bleepa will host a number of different diagnostic-led clinical pathways, starting initially with a novel direct access prostate screening service, pioneered by MIP, with further pathways across cardiac and Women's Health services to be onboarded later in the year.

 

Bleepa-CareLocker has been selected by MIP as its preferred digital partner based on its requirements to view clinical results data securely and remotely, to conduct asynchronous remote multidisciplinary team ("MDTs") meetings and to communicate results across provider sites, all through a single platform. It is anticipated that the pilot will also evaluate the possibility of patient direct access to results through Feedback's CareLocker application.

 

Patient volumes and associated revenue are expected to be modest in the early stages, post the evaluation and planning phase, however, management believes that the importance of this pilot cannot be understated. The fact that this is a direct translation of the NHS pathway work into the UK private healthcare sector highlights the important role that the private sector can play in supporting the NHS recovery and those patients affected by long waiting lists. It also demonstrates the huge versatility of the Bleepa-CareLocker platform to deliver care across sectors and is Feedback's first step towards opening a business line in the UK private sector.

 

Dr Tom Oakley, CEO Feedback plc said: "This exciting programme is the culmination of years of pathway work alongside UK clinicians. In Bleepa-CareLocker, we have developed a platform that delivers an unparalleled value proposition to clinical service partners, both in the NHS and now in the private sector. This is the first time that we have translated our NHS model into the private sector and we are excited to see the impact this could have for private patients and MIP as our clinical service partner and customer. We hope to use this pilot to open our opportunity in the UK private healthcare market, which was expected to reach £11 billion in 2023."

 

Steve Bird, CEO of Medical Imaging Partners said: "MIP is developing new models of diagnostic services in the independent diagnostic sector, including expanding its range of cancer and cardiac health checks and diagnostic tests. The company is also delivering a compelling range of direct-to-consumer diagnostic services that can offer patients choice and fast access at crucial times in their health and wellness journey. We see Bleepa-CareLocker as the ideal platform for us to help support these services and we were impressed by the capabilities and impact delivered in the NHS CDC pilots undertaken recently and look forward to seeing how this platform can help us to deliver our own pathways in the independent sector."

 

--Ends--

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Anesh Patel, CFO

+44 (0) 20 3997 7634

IR@fbk.com

 


Panmure Gordon (UK) Limited (NOMAD and Broker)

Emma Earl/Freddy Crossley (Corporate Finance)

Rupert Dearden (Corporate Broking)

+44 (0)20 7886 2500

 


Walbrook PR Ltd;

Tel: 020 7933 8780 or feedbackplc@walbrookpr.com

Nick Rome/Joe Walker

07748 325 236 or 07407 020 470

 

 

About Feedback

 

Feedback plc helps clinical teams to make better decisions faster for patients. We design products that enhance clinician access to patient data and to their colleagues. Our unique approach centres around individual patient episodes, into which we pull relevant clinical data from hospital systems and around which we build remote clinical teams for collaboration. As a result, we produce a digital infrastructure that makes patient data available to clinicians in multiple settings, in a format that enables them to meaningfully interact with it, providing flexibility to clinicians and free movement of patients between provider settings - clinicians can practice from anywhere and patients can attend any care provider for treatment. 

 

Our products Bleepa and CareLocker work together to deliver unparalleled value to our customers. Bleepa is our application layer and sits on top of CareLocker as our data layer. Bleepa is a clinician facing platform that displays clinical results from a patient's CareLocker at a certified and regulated quality, that is suitable for clinical use and enables dialogue on a patient-by-patient basis with colleagues through a secure, auditable chat interface that links back to the patient medical record. The CareLocker data storage model is built around the patient. Our vision is one where relevant clinical data is always available to the patient as well as to any care setting that they may attend - a federated data architecture with the patient as the tenant.  

 

The Company has a number of growth opportunities domestically and internationally across a range of markets including the NHS, the veterinary market and private healthcare providers and its highly scalable Software as a Service ("SaaS")-based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

 

About Medical Imaging Partnership

Medical Imaging Partnership has been delivering high-quality radiology and diagnostic services for both the NHS and the Independent sector for over a decade. The company has multiple sites and centres across the south of England, along with diagnostic centres in London, Manchester and Surrey. The sites provide MRI, CT and Dexa scanning along with Ultrasound services and other diagnostic services and tests. All locations are led by qualified and experienced healthcare professionals with a reputation for providing high quality care and service.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRKBLFLZLLXBBV
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Feedback PLC (FDBK)

0p (0.00%)
delayed 15:57PM